Provided by Tiger Fintech (Singapore) Pte. Ltd.

Iovance Biotherapeutics, Inc.

1.75
-1.4200-44.79%
Post-market: 1.750.00000.00%19:59 EDT
Volume:112.36M
Turnover:199.07M
Market Cap:584.39M
PE:-1.36
High:1.99
Open:1.94
Low:1.65
Close:3.17
Loading ...
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2020

Major Issues Report

8-K - Current report
Jun 19, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 19, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 12, 2020

Major Issues Report

8-K - Current report
Jun 09, 2020

Major Issues Report

8-K - Current report
Jun 02, 2020

Major Issues Report

8-K - Current report
May 29, 2020

Major Issues Report

8-K - Current report
May 27, 2020

Major Issues Report

8-K - Current report
May 22, 2020

Major Issues Report

8-K - Current report
May 08, 2020

Major Issues Report

Current report, items 8.01 and 9.01
May 05, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 05, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 25, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 24, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals